Peterson Wealth Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.66M Buy
14,557
+987
+7% +$212K 0.8% 36
2026
Q1
$2.95M Buy
13,570
+1,469
+12% +$326K 0.73% 40
2025
Q4
$2.76M Buy
12,101
+11,683
+2,795% +$2.66M 0.71% 39
2025
Q3
$2.72M Sell
418
-11,250
-96% -$2.29M 0.67% 37
2025
Q2
$2.17M Buy
11,668
+11,443
+5,086% +$2.13M 0.59% 44
2025
Q1
$47.1K Hold
225
0.01% 156
2024
Q4
$40K Hold
225
0.01% 154
2024
Q3
$44.4K Buy
+225
New +$42K 0.01% 158

Other funds holding ABBV

Peterson Wealth Services's ABBV Position: Q2 2026 in Review

Peterson Wealth Services increased its AbbVie (ABBV) stake by 7.3% in Q2 2026, buying an estimated $212K and bringing the position to 14,557 shares worth $3.66M. The position accounts for 0.8% of the portfolio, ranked #36.

Peterson Wealth Services first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Peterson Wealth Services held 14,557 shares of AbbVie worth $3.66M as of Q2 2026.
  • Peterson Wealth Services bought 987 AbbVie shares in Q2 2026, an estimated $212K.
  • AbbVie made up 0.8% of Peterson Wealth Services's portfolio in Q2 2026, its #36 holding.
  • Peterson Wealth Services first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Peterson Wealth Services's 13F filing for Q2 2026, filed 27 Jul 2026.